A detailed history of Easterly Investment Partners LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Easterly Investment Partners LLC holds 56,158 shares of COLL stock, worth $1.68 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
56,158
Previous 42,629 31.74%
Holding current value
$1.68 Million
Previous $1.37 Million 58.09%
% of portfolio
0.18%
Previous 0.12%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$31.4 - $39.07 $424,810 - $528,578
13,529 Added 31.74%
56,158 $2.17 Million
Q2 2024

Jul 25, 2024

SELL
$31.36 - $39.99 $219,520 - $279,930
-7,000 Reduced 14.1%
42,629 $1.37 Million
Q1 2024

May 03, 2024

SELL
$31.23 - $40.91 $687 - $900
-22 Reduced 0.04%
49,629 $1.93 Million
Q2 2023

Nov 13, 2023

BUY
$21.06 - $24.0 $518,539 - $590,928
24,622 Added 98.37%
49,651 $1.07 Million
Q1 2023

Nov 13, 2023

BUY
$23.0 - $29.88 $69,000 - $89,640
3,000 Added 13.62%
25,029 $600,000
Q1 2023

May 02, 2023

BUY
$23.0 - $29.88 $87,860 - $114,141
3,820 Added 17.67%
25,439 $610,000
Q4 2022

Nov 13, 2023

SELL
$16.14 - $23.55 $55,037 - $80,305
-3,410 Reduced 13.4%
22,029 $511,000
Q4 2022

Feb 10, 2023

SELL
$16.14 - $23.55 $6,617 - $9,655
-410 Reduced 1.86%
21,619 $501,000
Q2 2022

Aug 10, 2022

SELL
$14.22 - $20.88 $28,440 - $41,760
-2,000 Reduced 8.32%
22,029 $390,000
Q1 2022

May 13, 2022

BUY
$17.2 - $22.5 $413,298 - $540,652
24,029 New
24,029 $489,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.02B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Easterly Investment Partners LLC Portfolio

Follow Easterly Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Easterly Investment Partners LLC with notifications on news.